Publication | Closed Access

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

Hematological MalignancyOncologyPediatric HematologyMixed-phenotype Acute LeukemiaHematologyPediatricsCooperative GroupMaintenance TherapyFrench LameMedicineMyeloid Neoplasia